Endothelium-dependent inhibition of platelet aggregation.
about
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammationNitric oxide induces Zn2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiolResuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trialsNitric oxide: a review for veterinary surgeons.Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins.Pharmacology of endothelium-derived nitric oxide and nitrovasodilators.Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cellsFunctional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.Identification of arginine as a precursor of endothelium-derived relaxing factorPotential therapeutic action of nitrite in sickle cell diseaseeNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineeringEndogenous nitric oxide synthesis: biological functions and pathophysiology.The autoinhibitory control element and calmodulin conspire to provide physiological modulation of endothelial and neuronal nitric oxide synthase activity.Inhibitory effect of nitrite on coagulation processes demonstrated by thrombelastography.Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factorAdventures in vascular biology: a tale of two mediators.Effect of blood nitrite and nitrate levels on murine platelet function.Role of endothelium in the human uterine arteries during normal menstrual cycle.Is peroxisome proliferator-activated receptor gamma (PPARĪ³) a therapeutic target for the treatment of pulmonary hypertension?Mechanisms of human erythrocytic bioactivation of nitriteEvidence that platelets promote tube formation by endothelial cells on matrigel.A flow cytometric analysis of the inhibition of platelet reactivity due to nitrite reduction by deoxygenated erythrocytes.The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway.The discovery of nitric oxide and its role in vascular biology.Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system.Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aortaProstacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig.The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.Cyclic GMP-independent effects of nitric oxide on guinea-pig uterine contractility.Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxideStimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.A salivary vasodilator in the blood-sucking bug, Rhodnius prolixusThe role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase.Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitroSelective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
P2860
Q24564394-8AAC91C2-E0E5-4DD6-A0FA-4B34FDD9DAD2Q28343675-93FE743E-F3A0-45B4-A88C-F431CDF8930BQ30489561-E7359ABB-31E0-4622-8E86-918C10DA156BQ31921905-B6B87FE5-AA1A-4B54-A40E-8AD81A325910Q33376755-0A74B4B7-EF6B-4B12-8B51-A3DAFC584F0EQ33558813-07D9FDDA-59D2-45BA-84F1-A9D495879638Q33567885-FDB78BE5-46B4-4456-9EA0-67CD0AA426DCQ33640562-E7624B8C-C926-4BF1-951F-F72F6F89504DQ33672060-03C01AB3-A630-4E2B-A935-74694415376AQ33681568-76B9E165-4EB4-4DA8-BFE1-1B84C0C72EDCQ33728866-CD68C63B-8A1F-478E-8A55-8657646D6C42Q33814359-578583A1-BD9A-4310-AF44-3C9E7CD21E43Q33848398-3A09ED98-5A6E-4ED9-96FB-671A263721F2Q34047105-0F23D38B-2187-4644-8030-0017D71E05BBQ34127841-3C74F3BD-7199-45F5-9C08-DE2C0FE377A9Q34223247-9CA6CAA4-496A-469E-9D4A-AC3D4A809137Q34298013-2B77F215-1E4A-4071-9E62-0C02871BCC4AQ34515584-440CC091-5737-491E-95BC-A6FBACBFB438Q34577209-10FA7896-4647-43E9-84AA-E92EDD3E0AEAQ34792794-13D50FEB-74D2-495F-B6DE-B26B29D8D825Q34897476-DB0EDFF2-10E7-42AF-9260-00E9A81BC942Q34958622-3D963230-6EE7-47F9-8DCD-A3A562083607Q35028157-86A8BFD4-5323-48A9-B0AD-7E23640C0749Q35124111-FDDA85C1-2933-456A-87E6-1E91EC1CC8A0Q35335352-4A5847FE-66B2-433F-A26C-1F357A240644Q35566587-919877A3-C94C-4A42-9F64-9D3E0372232DQ35721799-5D400E40-BA68-4599-B539-6D05D5233FD6Q35750794-E5F267D4-EEF9-41BB-8CFE-59FF34827C4BQ35756071-B39E8371-842A-480F-BB88-8A8CCE913FB6Q35756085-48B5F843-C039-4AA6-9083-4539A820B3F7Q35870524-B7B4E24C-3D5F-4440-9F1F-3C2F51F26D57Q35884545-2A30A78A-56E9-40FF-899B-3F0ECEBC2934Q35884781-FC6903C4-E227-4E7B-A33B-126A82A93FA5Q35888186-FF3732A9-E03E-4B49-A178-FDD3E0F697F3Q35888559-E50C392F-B01D-405D-96C7-3EC659883C9CQ35925357-F5EA6F97-E540-47AA-8F72-1D587B05594EQ36058741-221774B1-ABB6-4175-8BFD-A522505F16F8Q36140718-39FFFC5C-44C9-4745-9214-FD8F9BD9AE6FQ36329615-CEDB710A-E95D-49E3-A5A8-8F641A380A37Q36329822-5966C91E-B147-4D5C-8CF7-50426A151F23
P2860
Endothelium-dependent inhibition of platelet aggregation.
description
1986 nĆ® lÅ«n-bĆ»n
@nan
1986幓ć®č«ę
@ja
1986幓č«ę
@yue
1986幓č«ę
@zh-hant
1986幓č«ę
@zh-hk
1986幓č«ę
@zh-mo
1986幓č«ę
@zh-tw
1986幓č®ŗę
@wuu
1986幓č®ŗę
@zh
1986幓č®ŗę
@zh-cn
name
Endothelium-dependent inhibition of platelet aggregation.
@en
Endothelium-dependent inhibition of platelet aggregation.
@nl
type
label
Endothelium-dependent inhibition of platelet aggregation.
@en
Endothelium-dependent inhibition of platelet aggregation.
@nl
prefLabel
Endothelium-dependent inhibition of platelet aggregation.
@en
Endothelium-dependent inhibition of platelet aggregation.
@nl
P2093
P2860
P1476
Endothelium-dependent inhibition of platelet aggregation.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1986.TB10218.X
P407
P577
1986-06-01T00:00:00Z